Mark Cabato News Today : Breaking News, Live Updates & Top Stories | Vimarsana

IRVINE, Calif.--(BUSINESS WIRE)--#ClinicalTrials--Immunis, Inc., a leading biotechnology company forging innovative cellular secretome therapies for age and disease-related immune decline, is delighted to announce that its Chief Business Officer, Mark Cabato, will be a keynote speaker at this year's Drug Discovery S...

IRVINE, Calif.--(BUSINESS WIRE)--#ClinicalTrials--Immunis, Inc., a private biotech and a leading innovator in cellular secretome therapies for age and disease-related immune decline, is honored to be selected as a finalist for the "Best Emerging Technology Company" by the Octane High Tech Awards (HTA). The HTA award...

IRVINE, Calif.--(BUSINESS WIRE)--Aug 18, 2023--